Chief Executive Officer Ian Parker’s Annual Letter to

New Post Public Reply Private Reply Replies (0) Message Board
Mauibound
397
Chief Executive Officer Ian Parker’s Annual Letter to ShareholdersPress Release | 07/14/2021

Holbrook, New York, July 14, 2021 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) (f.k.a. Emerald Organic Products Inc.) (“Healixa”, or the “Company”), a people-first digital organization that humanizes care by deploying simplified solutions for complex global challenges, today offers an open letter to shareholders from Chief Executive Officer Ian Parker which reports on the Company's 2021 year-to-date progress and shares his outlook for the balance of 2021.

Shareholders,

Healixa has created a staggering portfolio of “healing technologies”.  We have yet to unveil the full breath of our portfolio, but this letter will serve as a prelude to many of the exciting technologies to come. Collectively these ethically engineered technologies have the capability to produce substantial revenue while simultaneously having a positive healing impact on the world around us. 

The construction of this portfolio can be attributed to a select group of executives at Healixa who believe it is possible to “Do Well While Doing Good”.  I want to take a moment and thank them for their creativity, dedication, and execution. With them, Healixa is capable of becoming a premier Blue-Chip company. 

At Healixa we believe that our health is a reflection of what we eat, drink and, breathe. To that end, Healixa has amassed healing technologies that focus on building healthy communities. Our technology portfolio provides an omnichannel care approach and positive impact on the macro environmental challenges of our times. 

We have four core beliefs: 

Care Communities - We believe in building sustainable communities that focus on quality of life.Energy Sustainability - We believe that advanced green technology is critical to the future of human sustainability.Continuous Health - We believe that affordable comprehensive quality personal care should be attainable by all.Water Access - We believe access to clean drinking water is a necessity, and a human right.

How We Arrived at This Point

The healthcare industry, traditionally a slow adopter of automation and AI, was forced to rapidly accelerate the way we digitize healthcare in United States in order to address the COVID19 healthcare crisis. In the current on-demand economy, online commerce saves customers money and precious time. This added value is being presented to patients and the data conveys our patients are receptive and becoming active participants in their healthcare. The process of digitization is still in its early stages, which is evident with the number of fragmented solutions being offered. That said, Healixa is committed to championing this stage of digital care by offering an array of unique, convenient, personalized healing technologies via one simplified care ecosystem. 

Healixa’s calculated launch of novel technologies includes Healixa’s intellectual properties, patents, strategic collaborations, and partnerships. From incubation stage to market ready, our team of experts have focused on the foundational pieces needed to build an adaptable command center and product “Launch Pad”. A “Launch Pad” which will become home base for over 3 million covered lives and growing.

Although there is a competitive landscape, few companies can compete with our biometric scan technology.  With just the camera on a mobile device, we can now take your vital signs and report them back to your physician instantly. This revolutionary technology has separated us from the current pack. Our goal is to advance quickly to solidify and extend our current US healthtech position while continuing Healixa’s green tech global market initiatives. Independent and internal reviewers continue to validate the substantial opportunity in the vast markets we are targeting. 

It’s All About the Long Term

We believe that a fundamental measure of our success will be the shareholder value we create over the long term. This shareholder value is a direct result of our ability to broaden and solidify our position as market leaders in technology acquisition and development. The strength we possess as leaders in technology will command and ignite the expected revenues in our economic model. Technology leadership can translate directly to higher revenue, higher profitability, greater capital velocity, and correspondingly strength in returns on invested capital.

Our decisions have consistently reflected this focus. We first measure ourselves in terms of the metrics most indicative of our technology leadership: unique products, large addressable markets, patent protection, and creation of new categories. We have invested and will continue to invest aggressively to expand and leverage our technology portfolio, brand, and infrastructure as we fast track to establish an enduring franchise.

Because of our emphasis on the long term, we may make decisions and weigh tradeoffs differently than some companies. Accordingly, we want to share with you our fundamental management and decision-making approach so that you, our shareholders, may confirm that it is consistent with your investment philosophy:

Healixa relentlessly focuses on ethically engineering products that have a positive impact on the world around us.The team aims to make investment decisions in light of long-term market leadership considerations rather than short-term profitability considerations or short-term Wall Street reactions.We continuously measure our programs and the effectiveness of our investments analytically, and discontinue those that do not provide acceptable returns, and to increase our investment in those that respond best to the market at large. We will always strive to learn from both our successes and our failures.Our objective is to make bold rather than timid investment decisions where we see a sufficient probability of gaining market leadership advantages. When we see opportunities to broaden our technology portfolio in prominent new ways, we will do so without concern of Wall Street’s reaction. We will work hard to spend wisely and maintain our lean culture. We understand the importance of continually reinforcing a cost-conscious culture, particularly in a business still in its investment and growth stage.At Healixa, we balance our efforts on growth with emphasis on long-term profitability and capital management. At this stage, we choose to prioritize growth because we believe that scale is central to achieving the potential of our business model.The basis of our growth will be hiring and retaining versatile and talented individuals and continue to weight their compensation to stock options rather than cash. We know our success will be largely affected by our ability to attract and retain a motivated human capital base, each of whom must think like, and therefore must actually be, an owner.

With this foundation, we would like to turn to a review of our business focus, our progress in 2021, and our outlook for the future.

Bold Decisions and Future Share Price

As we turn from expansion and acquisition to execution, it is now time to begin to introduce a more complete picture of our technologies and how they all fit together. It is important to note one substantial difference between us and all of our care competitors; we have built a portfolio that not only addresses the symptoms of underlying health issues but also some of the major root causes of health issues. In this regard, one cannot look at healthcare and ignore the clean water crisis rapidly spreading throughout the globe. Lack of clean water is one of the major contributing factors to disease and illness. For this reason, Healixa has acquired a game changing patented technology to help transport clean water almost anywhere just from harvesting the air around us. This is not a concept technology, but rather a proven and tested technology which, when married to our healthtech, provides a true complete healing environment. Everyone that needs healthcare also needs clean water. 

This patented technology has already received significant interest from DoD experts, Special Operations Experts, United Nations, NGO’s, foreign governments, pharmaceutical companies and industry leaders. We will be releasing more on our healing technologies in the coming weeks, but the important take away is that our technology has no competition. We are entirely in a league of our own with this. 

With Water and Our Employees

The past year’s success is the product of a talented, smart, hard-working group, and I take great pride in serving as CEO of this talented team. Setting the bar high in our approach to hiring has been, and will continue to be, the single most important element of Healixa’s success. We diligently work towards building something meaningful while making a difference to our customers. Solutions we expect to last for generations. We feel incredibly fortunate to have a group of dedicated individuals whose sacrifices and passion transform Healixa daily. As we add new talented team members, I believe they will also be inspired, just as I am every day, by the dedication, commitment, and talent of our core team.

Goals for 2021

First, we want to rapidly deploy our uniquely unified digital care eco-system to the market. Second, we want to unveil the world our game changing water technology. We believe that the combination of these two initiatives will have a lasting positive impact on our world around us. This perfectly exemplifies Healixa’s mission to “Do Well While Doing Good.” The days of focusing only on the almighty bottom line at the expense of the world around us are over. We ALL need to be better. We need to look at the future through the lens of profitability by sustainability. Healixa’s portfolio of ethically engineered healing technologies put us in a unique position to drive and lead this philosophy.

Our continued efforts throughout these initial phases will remain to be expanding our reach, building out our brand and gaining knowledge from our consumers, partners, and key players in the industry. By making sound investments in our operations and infrastructure, we will be able to support consumer’s core needs; convenience, availability, and service while we grow. The organization also has major plans to go international. We understand firsthand the challenges with expanding our reach yet see significant opportunities for Healixa to better serve those overseas, such as participating in building sustainable communities. Our number one priority is to take pride in our investments and continue to find ways for expansion in human care.

As we grow our ecosystem, we are recognizing the vast amount of knowledge there is to absorb.  Time is of the essence, but our optimism, drive, and attention to detail is above all others. Our long-term vision for the Healixa brand will not come easily. We will face many challenges, and run into a few walls, but we will face them together. Our ability to continue turning each of those challenges into opportunities is what will drive shareholder value and make Healixa a household name.  With our team of functional, seasoned experts we will continue to refine Healixa’s digital footprint in the human care continuum. We feel good about where we are to date, and enthusiastic about future launches. We aren’t stopping anytime soon. 

At Healixa we are incredibly grateful to our market relationships for their patience and trust in our ventures, to each other for our dedication, and to our shareholders for their support and encouragement. 2021 has been an exciting year and we are ready for the future.

/s/ Ian Parker, CEO
https://www.otcmarkets.com/stock/EMOR/news/Ch...?id=311600

Emerald Organic Products, Inc. (EMOR) Stock Research Links

EMOR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lifeway Foods Set to Announce Q3 2026 Financial Results

Updated Category News Views 55

Anticipating Lifeway Foods’ Q3 Results Dust off your calendars and mark November 12, 2026—because that's when Lifeway Foods is putting its cards on the table for the third quarter. Nothing like a results call to see if your investments are eating right. NASDAQ:LWAY is no stranger to making some noise in the dairy aisle, thanks to their kefir—that fermented probiotic...

Continue Reading
LifeStance Expands Access to Esketamine, TMS

Updated Category News Views 53

LifeStance Health's Treatment Innovations Today, the spotlight is on LifeStance Health, as they're making waves with their treatment approaches for those battling stubborn, treatment-resistant depression. This isn't your run-of-the-mill attempt at tackling the beast—that familiar indifference masked as hope. No, this time around, they’re swinging with Esketamine and...

Continue Reading
CopperWood Senior Living Revives Historic Campus

Updated Category News Views 55

A Fresh Start for Peapack-Gladstone's Corporate Relic Dust off the pages of history—Peapack-Gladstone's old Pfizer/Beneficial Finance campus is getting a makeover, and boy, it’s not your run-of-the-mill renovation. We're talking adaptive reuse to the tune of nearly $200 million, morphing this architectural gem into CopperWood Senior Living. With all the office...

Continue Reading
Nicely Network: A Game-Changer for B2B SaaS Marketing

Updated Category News Views 173

Navigating the Reddit Marketing Labyrinth Life ain't a walk in the park for marketers these days, especially in the tech and SaaS arenas. Some folks seem to have cracked the code—or at least one part of it. Enter Nicely Network, which has just snagged the crown as the Best Reddit Marketing Agency for B2B SaaS & Software Companies, thanks to its knack for connecting...

Continue Reading
AI Literacy Framework Unfolds at AAC&U Conference

Updated Category News Views 30

Diverse Institutions Converge on AI Literacy A university conference isn't exactly where you'd expect seismic shifts, but this one's a bit of a dark horse. When big names like University of Phoenix, Boise State, Johns Hopkins, and the Medical University of South Carolina start syncing up their AI strategies, it feels like the sector's quietly brewing something big. At the...

Continue Reading
Hanwha's Big Bet: Tokenizing Real-World Assets with Chainlink

Updated Category News Views 15

Hanwha and Chainlink: A Game Changer in Tokenization What do Hanwha Investment & Securities, a heavyweight in Korea's finance scene, and Chainlink, the wizard of onchain finance, think they're up to? They're buddies now, locked and loaded, to tokenize real-world assets (RWAs). They're not just shaking hands; they're aiming to jiggle the global finance bedrock....

Continue Reading
Ruizhi Unveils Trio of High-Tech Paper Bag Machines

Updated Category News Views 21

Cutting-Edge Unveiling at All in Print China 2026 In the bustling expo halls of the Shanghai New International Expo Centre, Ruizhi Machinery rolled out the red carpet for its latest inventions, stealing the limelight at the All in Print China 2026. Now, these were not your run-of-the-mill paper bag makers; we're talking about a set of machines that could redefine the gig...

Continue Reading
Xerox Faces Probes After $130M Profit Forecast Slash

Updated Category News Views 45

When the Trust Breaks October 29, 2026 was a gut punch for Xerox investors. Watching the outlook dive by $130 million, the coffee-feeling in the trading rooms turned into something more bitter. A $105 million boost they once celebrated from tariff receivables now seems to be a fleeting shadow, as Xerox itself scuttles its adjusted operating income for 2026 to a range of...

Continue Reading
Tiny Fish Revolutionizes Vertebrate Gene Studies

Updated Category News Views 41

From Small Fish to Big Discoveries: Meet Danionella cerebrum Who would've thought a diminutive fish with a see-through body would give a jolt to the study of vertebrate genomes? Thanks to Danionella cerebrum, researchers at the Whitehead Institute have created the very first complete whole-body single-cell atlas of an adult vertebrate. Forget the Wall Street clamor for a...

Continue Reading
Instacart's Strong Q3 Amid DoorDash Acquisition News

Updated Category News Views 85

Bumper Profits and Bold Moves for Instacart Here's a twist in the grocery tech aisle—Instacart's got some hefty numbers rolling in for Q3 and a whopper of an acquisition announcement. What seemed like just another Tuesday in the market is shaken by Instacart's reveal of their third-quarter financial results, showcasing a significant year-over-year climb that would make...

Continue Reading

Top 5 Most Recently Viewed Articles

ASUR 4Q25 Earnings: Traffic Boost in Colombia, Mixed Signals

Updated Category News Views 165

Passenger Trends: A Bit of a Mixed Bag Traffic numbers can sometimes tell the real story, and for ASUR, it’s like reading a novel with plot twists. Colombia’s passenger traffic jumped 5.7%, fueled by robust international and domestic movements. Meanwhile, back in Puerto Rico? Things were not as rosy with a 3.1% drop due to lackluster domestic traffic. Mexico showed a...

Continue Reading
CVS Health's Unexpected Earnings Miss Sparks Analyst Optimism

Updated Category News Views 169

CVS Health Faces Challenges While Analysts Stay Positive Shares of CVS Health Corp (NYSE: CVS) have recently experienced a decline following the company’s preannouncement of a substantial earnings miss for the third quarter. This news comes during an exciting earnings season, generating considerable discussion among analysts and investors alike. Analyst Insights on CVS...

Continue Reading
Intercontinental Exchange Inc: Current Market Dynamics and Insights

Updated Category News Views 128

Understanding Intercontinental Exchange Inc's Market Position Intercontinental Exchange Inc (NYSE: ICE) has recently experienced a notable increase in short interest, which has risen by 8.59% since the last report. Currently, there are approximately 7.83 million shares that have been sold short, representing 1.39% of the total shares available for trading. Based on recent...

Continue Reading
Jason Passwaters: A Visionary Leader in Cybersecurity Innovation

Updated Category News Views 465

Jason Passwaters Receives Honorable Recognition Jason Passwaters, the dynamic CEO of Intel 471, has recently been celebrated for his significant contributions to the business world. His inclusion in the renowned Dallas 500 list acknowledges him as a pivotal figure among influential business leaders in the area. Passwaters’ Journey to Success With a strong foundation in...

Continue Reading
Investigation Launched into Greenwich LifeSciences, Inc.

Updated Category News Views 196

Investigation into Corporate Actions of Greenwich LifeSciences Greenwich LifeSciences, Inc. (NASDAQ: GLSI) finds itself under scrutiny as Purcell & Lefkowitz LLP initiates an investigation concerning potential breaches of fiduciary duties by the company’s directors. This investigation aims to address recent corporate actions that may not have aligned with the best...

Continue Reading